$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorigenesis

Cancer and metastasis reviews, v.15 no.1, 1996년, pp.53 - 76  

Papadimitrakopoulou, Vali A. ,  Shin, Dong M. ,  Hong, Waun K.

Abstract AI-Helper 아이콘AI-Helper

SummaryOne way to explain the development of head and neck cancer is through the theories of field cancerization, i.e., the exposure of an entire field of tissue to repeated carcinogenic insult, and multistep process, i.e., development of multiple cancers in a predisposed field through a series of r...

참고문헌 (237)

  1. CA Cancer CC Boring 44 7 1994 10.3322/canjclin.44.1.7 Boring CC, Squires TS, Tong T: Cancer statistics 1994. CA Cancer 44: 7?26, 1994 

  2. Int J Cancer DM Parkin 41 184 1988 10.1002/ijc.2910410205 Parkin DM, Laara E, Muir CS: Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41: 184?197, 1988 

  3. J Natl Cancer Inst SS DeVesa 87 175 1995 10.1093/jnci/87.3.175 DeVesa SS, Blot WJ, Stone BJ, Miller BA, Tarone RE, Fraumeni JF: Recent cancer trends in the United States. J Natl Cancer Inst 87: 175?182, 1995 

  4. N Engl J Med EE Vokes 328 184 1993 10.1056/NEJM199301213280306 Vokes EE, Weichselbaum RR, Lippman SM, Hong WK: Head and neck cancer. N Engl J Med 328: 184?193, 1993 

  5. Wolf G, Lippman SM, Laramore G, Hong WK: Head and neck cancer. In: Holland JF, Frei E, Bast RC, Kufe DW, Morton DL, Weichselbaum R (eds) Cancer Medicine, 3rd ed. Lea & Febiger, 1993, pp 1211?1275 

  6. Cancer Res MB Sporn 51 6215 1991 Sporn MB: Carcinogenesis and cancer-different perspectives on the same disease. Cancer Res 51: 6215?6218, 1991 

  7. J Clin Oncol SM Lippman 12 851 1994 10.1200/JCO.1994.12.4.851 Lippman SM, Benner SE, Hong WK: Cancer chemoprevention. J Clin Oncol 12: 851?873, 1994 

  8. Cancer Res C Boone 50 2 1990 Boone C, Kelloff GJ, Malone WE: Identification of candidate cancer chemoprevention agents and their evaluation in animal models and human clinical trials: A review. Cancer Res 50: 2?9, 1990 

  9. N Engl J Med FL Meyskens Jr 323 825 1990 10.1056/NEJM199009203231210 Meyskens FLJr: Coming of age: The chemoprevention of cancer. N Engl J Med 323: 825?827, 1990 

  10. N Engl J Med BL Weber 331 1523 1994 10.1056/NEJM199412013312214 Weber BL: Susceptibility genes for breast cancer. N Engl J Med 331: 1523?1524, 1994 

  11. Lancet Early Breast Cancer Trialists' Collaborative Group 339 1 1992 10.1016/0140-6736(92)90997-H Early Breast Cancer Trialists' Collaborative Group: Systemic temic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 339: 1?15, 71?84, 1992 

  12. Cancer Res WK Hong 53 5113 1994 Hong WK, Lippman SM, Wolf GT: Recent advances in head and neck cancer: Larynx preservation and cancer chemoprevention. Cancer Res 53: 5113?5120, 1994 

  13. J Clin Oncol K Heyne 10 1519 1992 10.1200/JCO.1992.10.10.1519 Heyne K, Lippman SM, Lee JS, Hong WK: The incidence of second primary tumors in long term survivors of small cell lung cancer. J Clin Oncol 10: 1519?1524, 1992 

  14. J Clin Oncol SM Lippman 11 1204 1993 10.1200/JCO.1993.11.7.1204 Lippman SM, Hong WK: Not yet standard: Retinoids versus second primary tumors. J Clin Oncol 11: 1204?1207, 1993 

  15. Eur J Cancer SE Benner 30 727 1994 10.1016/0959-8049(94)90282-8 Benner SE, Lippman SM, Hong WK: Chemoprevention of second primary tumors: A model for intervention trials. Eur J Cancer 30A: 727?729, 1994 

  16. J Natl Cancer Inst A Schatzkin 82 1746 1990 10.1093/jnci/82.22.1746 Schatzkin A, Freedman LS, Schiffman MN, Dawsey SM: Validation of intermediate endpoints in cancer research. J Natl Cancer Inst 82: 1746?1752, 1990 

  17. J Natl Cancer Inst M Zelen 80 1442 1988 10.1093/jnci/80.18.1442 Zelen M: Are primary cancer prevention trials feasible? J Natl Cancer Inst 80: 1442?1444, 1988 

  18. Cancer Res MS Stockman 52 2711 1992 Stockman MS, Gupta PK, Pressman NJ, Mulshine JL: Considerations in bringing a cancer biomarker to clinical application. Cancer Res 52 (suppl): 2711?2718, 1992 

  19. Curr Opin Oncol SM Lippman 7 234 1995 10.1097/00001622-199505000-00008 Lippman SM, Spitz MR, Huber MH, Hong WK: Strategies for chemoprevention study of premalignancy and second primary tumors in the head and neck. Curr Opin Oncol 7: 234?241, 1995 

  20. J Natl Cancer Inst SM Lippman 82 555 1990 10.1093/jnci/82.7.555 Lippman SM, Lee JS, Lotan R, Hittelman W, Wargovich MJ, Hong WK: Biomarkers as intermediate end points in chemoprevention trials. J Natl Cancer Inst 82: 555?560, 1990 

  21. SM Lippman 329 1995 Cancer Prevention and Control Lippman SM, Benner SE, Hong WK: The chemoprevention of cancer. In: Greenwald P, Kramer BS, Weed DL (eds) Cancer Prevention and Control. Marcel Dekker Inc. New York, 1995, pp 329?352 

  22. Cancer Res S Sharma 54 5848 1994 Sharma S, Stutzman JD, Kellof GJ, Steele VE: Screening of potential chemopreventive agents using biochemical markers of carcinogenesis. Cancer Res 54: 5848?5855, 1994 

  23. Cancer Epidemiol Biomarkers Prev DM Shin 3 697 1994 Shin DM, Hittelman WN, Hong WK: Biomarkers in upper aerodigestive tract tumorigenesis. Cancer Epidemiol Biomarkers Prev 3: 697?709, 1994 

  24. Clin Cancer Res WK Hong 1 677 1995 Hong WK, Lippman SM, Hittelman WN, Lotan R: Retinoid chemoprevention of aerodigestive cancer: From basic research to the clinic. Clin Cancer Res 1: 677?686, 1995 

  25. Cancer DP Slaughter 6 963 1953 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q Slaughter DP, Southwick HW, Smejkal W: Field cancerization in oral stratified squamous epithelium: Clinical implications of multicentric origin. Cancer 6: 963?968, 1953 

  26. SM Lippman 93 1992 Important Advances in Oncology Lippman SM, Hong WK: Retinoid chemoprevention of upper aerodigestive tract carcinogenesis. In: De Vita VT, Hellman S, Rosenberg SA (eds) Important Advances in Oncology. JB Lippincot Co, Philadelphia, 1992, pp 93?109 

  27. Int J Radiat Oncol Biol Phys JS Cooper 17 449 1989 10.1016/0360-3016(89)90094-1 Cooper JS, Pajak TF, Rubin P, Tupchong L, Brady LW, Leibel SA, Laramore GE, Marcial VA, Davis LW, Cox JD: Second malignancies in patients who have head and neck cancers: Incidence, effect on survival and implications for chemoprevention based on the RTOG experience. Int J Radiat Oncol Biol Phys 17: 449?456, 1989 

  28. Am J Otolaryngol N Vries De 9 151 1988 10.1016/S0196-0709(88)80021-8 De Vries N, Snow GB: Prevention of second primary cancers in head and neck patients: New perspectives. Am J Otolaryngol 9: 151?154, 1988 

  29. Int J Radiat Oncol Biol Phys SM Lippman 17 691 1989 10.1016/0360-3016(89)90126-0 Lippman SM, Hong WK: Second malignant tumors in head and neck squamous cell carcinoma: The overshadowing threat for patients with early stage disease (Editorial). Int J Radiat Oncol Biol Phys 17: 691?694, 1989 

  30. J Clin Oncol BE Johnson 13 101 1995 10.1200/JCO.1995.13.1.101 Johnson BE, Linnoila RI, Williams JP, Venzon DJ, Okunieff P, Anderson GB, Richardson GE: Risk of second aerodigestive cancers increase in patients who survive free of small cell lung cancer for more than two years. J Clin Oncol 13: 101?111, 1995 

  31. Lancet BS Tepperman 2 547 1981 10.1016/S0140-6736(81)90938-7 Tepperman BS, Fitzpatrick PJ: Second respiratory and upper digestive tract cancers after oral cancer. Lancet 2: 547?549, 1981 

  32. Int J Radiat Oncol Biol Phys S McDonald 17 457 1989 10.1016/0360-3016(89)90095-3 McDonald S, Haie C, Rubin R, Nelson D, Divers LD: Second malignant tumors in patients with laryngeal carcinoma: Diagnosis, treatment and prevention. Int J Radiat Oncol Biol Phys 17: 457?465, 1989 

  33. Int J Radiat Oncol Biol Phys JT Licciardello 17 467 1989 10.1016/0360-3016(89)90096-5 Licciardello JT, Spitz MR, Hong WK: Multiple primary cancer in patients with cancer of the head and neck: Second cancer of the head and neck, esophagus and lung. Int J Radiat Oncol Biol Phys 17: 467?476, 1989 

  34. Arch Otolaryngol B Vikram 110 564 1984 10.1001/archotol.1984.00800350006003 Vikram B: Changing patterns of failure in advanced head and neck cancer. Arch Otolaryngol 110: 564?565, 1984 

  35. N Engl J Med O Auerbach 265 253 1961 10.1056/NEJM196108102650601 Auerbach O, Stout AP, Hammond EC, Garfinkle L: Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer. N Engl J Med 265: 253?267, 1961 

  36. Proc Natl Acad Sci USA CM Aldaz 84 2029 1987 10.1073/pnas.84.7.2029 Aldaz CM, Conti CJ, Klein-Szanto AJP, Slaga TJ: Progressive dysplasia and aneuploidy are hallmarks of mouse skin papillomas: Relevance to malignancy. Proc Natl Acad Sci USA 84: 2029?2032, 1987 

  37. J Clin Pathol F Konishi 35 830 1982 10.1136/jcp.35.8.830 Konishi F, Morson BC: Pathology of colorectal carcinomas: A colonoscopic survey. J Clin Pathol 35: 830?841, 1982 

  38. Cancer Res C Boone 52 1651 1992 Boone C, Kelloff GJ, Steele VE: Natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy. Cancer Res 52: 1651?1659, 1992 

  39. Cancer Res G Sozzi 52 6079 1992 Sozzi G, Miozzo M, Donghi R, Pilotti S, Cariani CT, Pastorino V, Della Porta G, Pierotti MA: Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res 52: 6079?6082, 1992 

  40. Cancer Res JS Lee 47 6349 1987 Lee JS, Pathak S, Hopwood V, Tomasovic B, Mullins JD, Baker FL, Spitzer G, Neidhart JA: Involvement of chromosome 7 in primary lung cancer and nonmalignant normal lung tissue. Cancer Res 47: 6349?6352, 1987 

  41. WN Hittelman 41 1991 Implication for Chemoprevention Approaches in Chemoprevention Cancer Hittelman WN, Lee JS, Cheong N, Shin DM, Hong WK: The chromosome view of ?field cancerization? and multistep tumorigenesis. In: Pastorino U, Hong WK (eds) Implication for Chemoprevention Approaches in Chemoprevention Cancer. Thieme Verlag, Stuttagart, 1991, pp 41?47 

  42. Am J Pathol SY Kim 142 307 1993 Kim SY, Lee JS, Ro JY, Gay M, Hong WK, Hittelman WN: Interphase cytogenetics in paraffin sections of lung tumors by non-isotopic in situ hybridization: Mapping genotype/phenotype heterogeneity. Am J Pathol 142: 307?317, 1993 

  43. Cancer Res N Voravud 53 2874 1993 Voravud N, Shin DM, Ro JY, Lee JS, Hong WK, Hittelman WN: Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis. Cancer Res 53: 2874?2883, 1993 

  44. Oncogene V Sundaresan 7 1989 1992 Sundaresan V, Ganly P, Hasleton P, Rudd R, Sinhha G, Bleehen NM, Rabbits P: p53 and chromosome 3 abnormalities, characteristic of malignant lung tumors, are detectable in preinvasive lesions of the bronchus. Oncogene 7: 1989?1997, 1992 

  45. JAMA J Hung 273 558 1995 10.1001/jama.1995.03520310056030 Hung J, Kishimoto Y, Sugio K, Virmani A, McIntire DD, Minna JD, Gazdar AF: Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 273: 558?563, 1995 

  46. J Natl Cancer Inst Y Kishimoto 87 1224 1995 10.1093/jnci/87.16.1224 Kishimoto Y, Sugio K, Hung JY, Virmani AK, McIntire DD, Minna JD, Gazdar A: Allele-specific loss in the chromosome 9p loci in preneoplastic lesion accompanying non-small cell lung cancer. J Natl Cancer Inst 87: 1224?1229, 1995 

  47. Cancer Res K Sugio 54 5811 1994 Sugio K, Kishimoto Y, Virmani A, Hung JY, Gazdar AF: K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas. Cancer Res 54: 5811?5915, 1994 

  48. Cancer Res KY Chung 53 1676 1993 Chung KY, Muchopadhyay T, Casson A, Ro JY, Goepfert H, Hong WK, Roth JA: Discordant p53 mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 53: 1676?1683, 1993 

  49. Cancer Res E Farber 44 4217 1984 Farber E: The multistep nature of cancer development. Cancer Res 44: 4217?4223, 1984 

  50. J Engl J Med B Vogelstein 319 525 1988 10.1056/NEJM198809013190901 Vogelstein B, Fearon ER, Hamilton SR: Genetic alterations during colorectal tumor development. J Engl J Med 319: 525?532, 1988 

  51. Oral Surg Oral Med Oral Pathol JE Bouquot 65 199 1985 10.1016/0030-4220(88)90166-1 Bouquot JE, Weiland LH, Kurland LT: Leukoplakia and carcinoma in situ synchronously associated with invasive oral/oropharyngeal carcinoma in Rochester, Minn., 1935?1984. Oral Surg Oral Med Oral Pathol 65: 199?207, 1985 

  52. Cancer J Einhorn 20 2189 1967 10.1002/1097-0142(196712)20:12<2189::AID-CNCR2820201218>3.0.CO;2-M Einhorn J, Wersall J: Incidence of oral carcinoma in patients with leukoplakia of the oral mucosa. Cancer 20: 2189?2193, 1967 

  53. N Engl J Med AL Mashberg 297 109 1977 10.1056/NEJM197707142970212 Mashberg AL: Erythroplasia vs. leukoplakia in the diagnosis of ealry asymptomatic oral squamous carcinoma. N Engl J Med 297: 109?110, 1977 

  54. N Engl J Med G Sklar 315 1544 1986 10.1056/NEJM198612113152408 Sklar G: Oral leukoplakia. N Engl J Med 315: 1544?1546, 1986 

  55. Cancer S Silverman Jr 53 563 1984 10.1002/1097-0142(19840201)53:3<563::AID-CNCR2820530332>3.0.CO;2-F Silverman SJr, Gorsky M, Lozada F: Oral leukoplakia and malignant transformation: A follow-up study of 257 patients. Cancer 53: 563?568, 1984 

  56. J Nutr Growth Cancer HF Stich 4 9 1987 Stich HF: Micronucleated exfoliated cells as indicators for genotoxic damage and as markers in chemoprevention trials. J Nutr Growth Cancer 4: 9?18, 1987 

  57. Can J Physiol Pharmacol MP Rosin 65 483 1987 10.1139/y87-083 Rosin MP, Dunn BP, Stich HF: Use of intermediate endpoints in quantitating the response of precancerous lesions to chemopreventive agents. Can J Physiol Pharmacol 65: 483?487, 1987 

  58. Int J Cancer SM Lippman 45 811 1990 10.1002/ijc.2910450503 Lippman SM, Peters E, Wargovich M: Bronchial micronuclei as a marker of an ?early? stage of carcinogenesis in human tracheobronchial epithelium. Int J Cancer 45: 811?815, 1990 

  59. Lancet HF Stich 1 1204 1984 10.1016/S0140-6736(84)91692-1 Stich HF, Rosin MP, Vallejera MO: Reduction with vitamin A and beta-carotene administration of the proportion of micronucleated buccal mucosal cells in Asian betel nut and tobacco chewers. Lancet 1: 1204?1206, 1984 

  60. Int J Cancer HF Stich 42 195 1988 10.1002/ijc.2910420209 Stich HF, Rosin MP, Hornby AP: Remission of oral leukoplakias and micronuclei in tobacco/betel quid chewers treated with beta-carotene and beta-carotene and vitamin A. Int J Cancer 42: 195?199, 1988 

  61. J Natl Cancer Inst N Munoz 79 687 1987 Munoz N, Hayashi M, Bang LJ, Wahrendorf J, Massimo C, Bosch FX: Effect of riboflavin, retinol, and zinc on micronuclei of buccal mucosa and of esophagus: A randomized double-blind intervention study in China. J Natl Cancer Inst 79: 687?691, 1987 

  62. Int J Cancer SE Benner 52 44 1992 10.1002/ijc.2910520110 Benner SE, Lippman SM, Wargovich MJ, Velasco M, Peters EJ, Morice RC, Hong WK: Micronuclei in bronchial biopsy specimens from heavy smokers: Characterization of an intermediate marker of lung carcinogenesis. Int J Cancer 52: 44?47, 1992 

  63. Int J Cancer SE Benner 59 457 1994 10.1002/ijc.2910590403 Benner SE, Lippman SM, Wargovich MJ, Lee JJ, Velasco M, Martin JW, Toth BB, Hong WK: Micronuclei, a biomarker for chemoprevention trials: Results of a randomized study in oral premalignancy. Int J Cancer 59: 457?459, 1994 

  64. F Mitelman 1988 Catalog of chromosome aberrations in cancer 3rd ed. Mitelman F: Catalog of chromosome aberrations in cancer, 3rd ed. Alan R. Liss, New York, 1988 

  65. Genes Chromosom Cancer Y Jin 2 198 1990 10.1002/gcc.2870020306 Jin Y, Higashi K, Mandahl N, Heim S, Wennerberg J, Biorklund A, Dictor M, Mitelman F: Frequent rearrangement of chromosomal bands 1p22 and 11q13 in squamous cell carcinoma of the head and neck. Genes Chromosom Cancer 2: 198?204, 1990 

  66. Cancer Genet Cytogenet P Osella 59 73 1992 10.1016/0165-4608(92)90162-2 Osella P, Carlson A, Wyandt H, Milungky A: Cytogenetic studies of eight squamous cell carcinomas of the head and neck. Cancer Genet Cytogenet 59: 73?78, 1992 

  67. Cancer Res Y Jin 53 2140 1993 Jin Y, Mertens F, Mandahl N, Heim S, Olegard C, Wennerberg J, Biorklund A, Mitelman F: Chromosome abnormalities in eighty-three head and neck squamous cell carcinomas: Influence of culture conditions on karyotypic pattern. Cancer Res 53: 2140?2146, 1993 

  68. Cancer Genet Cytogenet JR Tessier 37 103 1989 10.1016/0165-4608(89)90080-0 Tessier JR: The chromosomal analysis of human solid tumors: A triple challenge. Cancer Genet Cytogenet 37: 103?125, 1989 

  69. Anticancer Res TE Carey 13 2561 1993 Carey TE, Van Dyke DL, Worsham MJ: Nonrandom chromosome aberrations and clonal populations in head and neck cancer. Anticancer Res 13: 2561?2568, 1993 

  70. Genes Chromosom Cancer DL Dyke Van 9 192 1994 10.1002/gcc.2870090308 Van Dyke DL, Worsham MJ, Benninger MS, Krause CJ, Baker SR, Wolf GT, Drumheller T, Tilley BC, Carey TE: Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes Chromosom Cancer 9: 192?206, 1994 

  71. Cancer Res JM Cowan 53 5542 1993 Cowan JM, Beckett MA, Weichselbaum RR: Chromosome changes characterizing in vitro response to radiation in human squamous cell carcinoma lines. Cancer Res 53: 5542?5547, 1993 

  72. Cancer Res JS Lee 47 6349 1987 Lee JS, Pathak S, Hopwood V, Tomasovic B, Mullins TD, Baker FL, Spitzer G, Neidhart JA: Involvement of chromosome 7 in primary lung tumor and nonmalignant normal lung tissue. Cancer Res 47: 6349?6352, 1987 

  73. Genes Chromosom Cancer F Mertens 4 235 1992 10.1002/gcc.2870040308 Mertens F, Jin Y, Heim S, Mandahl N, Johnsson N, Mertens O, Persson B, Salesmark L, Wennerberg J, Mitelman F: Clonal structural chromosome aberration in nonneoplastic cells of the skin and upper aerodigestive tract. Genes Chromosom Cancer 4: 235?240, 1992 

  74. Proc Natl Acad Sci USA D Pinkel 83 2934 1986 10.1073/pnas.83.9.2934 Pinkel D, Straume T, Gray JW: Cytogenetic analysis using quantitative, high sensitivity fluorescence hybridization. Proc Natl Acad Sci USA 83: 2934?2938, 1986 

  75. Hum Genet T Cremer 80 235 1988 10.1007/BF01790091 Cremer T, Lichter P, Borde J, Ward DC, Manuelidis L: Detection of chromosome aberrations in metaphase and interphase tumor cells by in situ hybridization using chromosome-specific library probes. Hum Genet 80: 235?246, 1988 

  76. Cancer Res K Matsumura 52 3474 1992 Matsumura K, Kallioniemi A, Kallioniemi O, Chen L, Smith HS, Pinkel D, Gray J, Waldman FM: Deletion of chromosome 17q loci in breast cancer cells detected by fluorescence in situ hybridization. Cancer Res 52: 3474?3477, 1992 

  77. J Clin Pathol EPJ Arnoldus 44 503 1991 Arnoldus EPJ, Dreef EJ, Noordemeer IA, Verheggen MM, Thierry RF, Peters ACB, Cornelisse CJ, Van der Ploeg M, Raap AK: Feasibility of in situ hybridization with chromosome-specific DNA probes on paraffin wax-embedded tissue. J Clin Pathol 44: 503?513, 1991 

  78. Mod Pathol AHN Hopman 4 503 1991 Hopman AHN, Van Hooren E, Van de Kaa CA, Vooijs PGP, Ramaekers FCS: Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers. Mod Pathol 4: 503?513, 1991 

  79. Breast Cancer Res Treat K Dhingra 23 201 1992 10.1007/BF01833516 Dhingra K, Sahin A, Supak J, Kim SY, Hortobagyi G, Hittelman WN: Chromosome in situ hybridization on formalin-fixed mammary tissue using non-isotopic, non-fluorescent probes: Technical considerations and biological implications. Breast Cancer Res Treat 23: 201?210, 1992 

  80. J Natl Cancer Inst JS Lee 85 1951 1993 10.1093/jnci/85.23.1951 Lee JS, Kim SY, Hong WK, Lippman SM, Ro JY, Gay ML, Hittelman WN: Detection of chromosomal polysomy in oral leukoplakia, a premalignant lesion. J Natl Cancer Inst 85: 1951?1954, 1993 

  81. Science (Washington, DC) A Kallioniemi 258 818 1992 10.1126/science.1359641 Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D: Comparative genomic hybridization for cytogenetic analysis of solid tumors. Science (Washington, DC) 258: 818?821, 1992 

  82. Cancer Res MR Speicher 55 1010 1995 Speicher MR, Howe C, Crotty P, Du Manoir S, Costa J, Ward DC: Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res 55: 1010?1013, 1995 

  83. Cancer Res AG Knudson Jr 45 1437 1985 Knudson AGJr: Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 45: 1437?1443, 1985 

  84. Am J Hum Genet JL Weber 44 388 1989 Weber JL, May PE: Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 44: 388?396, 1989 

  85. Cancer Res KW Ah-See 54 617 1994 Ah-See KW, Cooke TG, Pickford IR, Soutar D, Balmain A: An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res 54: 617?1621, 1994 

  86. Cancer Res H Nawroz 54 1152 1994 Nawroz H, Van der Riet P, Hruban RH, Koch WM, Ruppert JM, Sidransky D: Allelotype of head and neck squamous cell carcinoma. Cancer Res 54: 1152?1155, 1994 

  87. Cancer AK El-Naggar 72 881 1993 10.1002/1097-0142(19930801)72:3<881::AID-CNCR2820720337>3.0.CO;2-Q El-Naggar AK, Lee MS, Wang G, Luna MA, Goepfert H, Batsakis JG: Polymerase chain reaction-based restriction fragment length polymorphism analysis of the short arm of chromosome 3 in primary head and neck squamous carcinoma. Cancer 72: 881?886, 1993 

  88. Cancer Res F Latif 52 1451 1992 Latif F, Fivosh M, Glenn G, Tory K: Chromosome 3p deletions in head and neck carcinomas. Statistical ascertainment of allelic loss. Cancer Res 52: 1451?1456, 1992 

  89. Cancer Res S Yokoyama 52 873 1992 Yokoyama S, Yamakawa K, Tsuchiya E, Murata M, Sakiyama S, Nakamura Y: Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res 52: 873?877, 1992 

  90. Cancer Treat Res RA Kratzke 63 61 1992 10.1007/978-1-4615-3088-6_3 Kratzke RA, Simizu E, Kaye FJ: Oncogenes in human lung cancer. Cancer Treat Res 63: 61?85, 1992 

  91. Oncogene K Hibi 7 445 1992 Hibi K, Takahashi T, Yamakawa K, Ueda R, Sekido Y, Ariyoshi Y: Three distinct regions involved in 3p deletions in human lung cancer. Oncogene 7: 445?449, 1992 

  92. Proc Natl Acad Sci USA AM Killary 89 10877 1992 10.1073/pnas.89.22.10877 Killary AM, Wolf ME, Giambernardi TA, Naylor SL: Definition of tumor suppressor locus within human chromosome 3p21?22. Proc Natl Acad Sci USA 89: 10877?10881, 1992 

  93. Cancer Res R Maestro 53 5775 1993 Maestro R, Gasparotto D, Vuksavljevic T, Barzan L, Sulfaro S, Boiocchi M: Three discrete regions of deletion in head and neck cancers. Cancer Res 53: 5775?5779, 1993 

  94. Cancer Res CL Wu 54 6484 1994 Wu CL, Sloan P, Read AP, Harris R, Thakker N: Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity. Cancer Res 54: 6484?6488, 1994 

  95. Science (Washington, DC) KW Kinzler 253 661 1991 10.1126/science.1651562 Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, McKechnie D, Finniear R, Markham A, Groffen J, Boguski MS, Altschul SF, Horii A, Ando H, Miyoshi Y, Miki Y, Nishisho I, Nakamura Y: Identification of FAP locus genes from chromosome 5q21. Science (Washington, DC) 253: 661?665, 1991 

  96. Proc Natl Acad Sci USA RF Boynton 89 3385 1992 10.1073/pnas.89.8.3385 Boynton RF, Blount PL, Yin J, Brown VL, Huang Y, Tong Y, McDaniel T, Newkirk C, Resan JH, Raskind WH, Haggit RC, Reid BJ, Meltzer SJ: Loss of heterozygosity involving the APC and MCC genetic loci in the majority of human esophageal cancers. Proc Natl Acad Sci USA 89: 3385?3388, 1992 

  97. Br J Cancer AM Thompson 68 64 1993 10.1038/bjc.1993.287 Thompson AM, Morris RG, Wallace M, Wyllie AH, Sreel CM, Carter DC: Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer. Br J Cancer 68: 64?68, 1993 

  98. Genomics OI Olopade 14 437 1992 10.1016/S0888-7543(05)80238-1 Olopade OI, Bohlander SK, Pomykala H, Maltepe E, Van Melle E, Le Beau MM, Diaz MO: Mapping of the shortest region of overlap of deletions of the short arm of chromosome 9 associated with human neoplasia. Genomics 14: 437?443, 1992 

  99. Cancer Res CD James 53 3674 1993 James CD, Collins VP, Allalunis-Turner MJ, Days RS: Localization of chromosome 9p homozygous deletions in glioma cell lines with markers constituting a continuous linkage map. Cancer Res 53: 3674?3676, 1993 

  100. Proc Natl Acad Sci USA JW Fountain 89 10557 1992 10.1073/pnas.89.21.10557 Fountain JW, Karayiorgou M, Ernsthoff MS, Kirkwood JM, Vlock DR, Titus-Ernsthoff L, Bouchard B, Vijayasaradhi S, Houghton AN, Lahti J, Kidd VJ, Housman DE, Dracopoli NC: Homozygous deletions within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci USA 89: 10557?10561, 1992 

  101. Cancer Res P Cairns 54 1422 1994 Cairns P, Tokino K, Eby E, Sidransky D: Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction. Cancer Res 54: 1422?1424, 1994 

  102. Cancer Res A Merlo 54 640 1994 Merlo A, Gabrielson E, Askin F, Sidransky D: Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res 54: 640?642, 1994 

  103. Oncogene GA Lammie 6 439 1991 Lammie GA, Fantl V, Smith R, Schuuring E, Brookes S, Michalides R, Dickson C, Arnold A, Peters G: D11S287, a putative oncogene on 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 6: 439?444, 1991 

  104. Oncogene JR Berenson 4 1111 1989 Berenson JR, Yan J, Micke RA: Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas. Oncogene 4: 1111?1116, 1989 

  105. Oncogene KD Sommers 5 915 1990 Sommers KD, Cartwright SL, Schechter GL: Amplifications in the int-2 gene in human head and neck squamous cell carcinomas. Oncogene 5: 915?920, 1990 

  106. Cancer Res GH Yoo 54 4603 1994 Yoo GH, Xu HJ, Brennan JA, Westra W, Hruban RH, Koch WM, Benedict WF, Sidransky D: Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromsome 13q in head and neck squamous cell carcinoma. Cancer Res 54: 4603?4606, 1994 

  107. Cell A Hall 1 921 1990 10.1016/0092-8674(90)90054-I Hall A: ras and GAP: Who's controlling whom? Cell 1: 921?923, 1990 

  108. Cancer Res JL Bos 49 4682 1989 Bos JL: ras oncogenes in human cancer: A review. Cancer Res 49: 4682?4689, 1989 

  109. Oncogene NR Lemoine 4 159 1989 Lemoine NR, Mayall ES, Wyllie FS, Williams ED, Goyns M, Stringer B, Wynford-Thomas D: High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene 4: 159?164, 1989 

  110. Oncogene KV Vanathan Vis 3 77 1988 Vis Vanathan KV, Pocock RD, Summerhayes IC: Preferential and novel activation of H-ras in human bladder carcinomas. Oncogene 3: 77?86, 1988 

  111. Cell C Almoguera 53 549 1988 10.1016/0092-8674(88)90571-5 Almoguera C, Shibata D, Forrester K, Martin J, Armheim N, Perucho M: Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53: 549?554, 1988 

  112. Nature (Lond.) JL Bos 327 293 1987 10.1038/327293a0 Bos JL, Fearon ER, Hamilton JR, Verlaan-de Vries M, Van Boom JH, Van der Eb AJ, Vogelstein B: Prevalence of ras gene mutations in human colorectal cancer. Nature (Lond.) 327: 293?297, 1987 

  113. Cancer Res S Rodenhuis 48 5738 1988 Rodenhuis S, Slebos RJ, Boot AJM, Evers SG, Mooi NJ, Wagenaar SS, Van Bodegom PC, Bos JL: Incjdence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res 48: 5738?5741, 1988 

  114. Oncogene Y Suzuki 5 1037 1990 Suzuki Y, Orita M, Shiraishi M, Hayashi K, Sekiya T: Detection of ras oncogene mutations in human lung cancers by single strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 5: 1037?1043, 1990 

  115. J Virol ME Furth 43 294 1982 10.1128/JVI.43.1.294-304.1982 Furth ME, Davis LJ, Fleurdelys B, Scolnick EM: Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family. J Virol 43: 294?304, 1982 

  116. Br J Cancer ZM Sheng 62 398 1990 10.1038/bjc.1990.306 Sheng ZM, Barrois M, Klijanienko J, Micheau C, Richard JM, Rio G: Analysis of the c-Ha-ras-1 gene for deletion, mutation, amplification and expression in lymph node metastases of human head and neck cancer. Br J Cancer 62: 398?404, 1990 

  117. Br J Cancer G Rumsby 61 365 1990 10.1038/bjc.1990.80 Rumsby G, Carter RC, Gusterson BA: Low incidence of ras oncogene activation in human squamous cell carcinomas. Br J Cancer 61: 365?368, 1990 

  118. Br J Cancer D Saranath 63 573 1991 10.1038/bjc.1991.133 Saranath D, Chang SE, Bhoite LT, Panchall RG, Kerr IB, Mehta AR, Johnson NW, Deo MG: High frequency mutation in codons 12 and 61 of Ha-ras oncogene in tobacco related human oral carcinomas. Br J Cancer 63: 573?578, 1991 

  119. J Oral Pathol Med MYP Kuo 24 255 1995 10.1111/j.1600-0714.1995.tb01178.x Kuo MYP, Chang HH, Hahn LJ, Wang JT, Chiang CP: Elevated ras p21 expression in oral premalignant lesions and squamous cell carcinomas in Taiwan. J Oral Pathol Med 24: 255?260, 1995 

  120. Cell T Yamamoto 35 71 1983 10.1016/0092-8674(83)90209-X Yamamoto T, Nishida T, Miyajima M, Kawai S, Ooi T, Toyoshima K: The erb B gene of the avian erythroblastosis virus is a member of the src gene family. Cell 35: 71?78, 1983 

  121. Cell R Derynck 54 593 1988 10.1016/S0092-8674(88)80001-1 Derynck R: Transforming growth factor-?. Cell 54: 593?595, 1988 

  122. J Biol Chem S Cohen 255 4834 1980 10.1016/S0021-9258(19)85573-4 Cohen S, Carpenter G, King L: Epidermal growth factor receptor protein kinase interactions. J Biol Chem 255: 4834?4842, 1980 

  123. J Biol Chem H Ushiro 255 8363 1980 10.1016/S0021-9258(18)43497-7 Ushiro H, Cohen S: Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A431 cell membranes. J Biol Chem 255: 8363?8365, 1980 

  124. J Cell Biochem S Cohen 29 195 1985 10.1002/jcb.240290304 Cohen S, Ushiro H, Stoscheck C, Gill GN: Regulation of the epidermal growth factor by phosphorylation. J Cell Biochem 29: 195?208, 1985 

  125. Science (Washington, DC) TJ Velu 238 1408 1987 10.1126/science.3500513 Velu TJ, Beguinot L, Vass WC, Willingham MC, Merlino GT, Pastan I, Lowy DR: Epidermal growth factor dependent transformation by a human EGF receptor protooncogene. Science (Washington, DC) 238: 1408?1410, 1987 

  126. Cancer Res A Eisbruch 47 3603 1987 Eisbruch A, Blick M, Lee JS, Sacks PJ, Gutterman J: Analysis of epidermal growth factor receptor gene in fresh human head and neck tumors. Cancer Res 47: 3603?3605, 1987 

  127. Carcinogenesis R Todd 10 1553 1989 10.1093/carcin/10.8.1553 Todd R, Donoff BR, Gertz R, Chang A, Chow P, Matossian K, McBride J, Chiang T, Gallagher GT, Wong D: TGF-? and EGF receptor mRNAs in human oral cancers. Carcinogenesis 10: 1553?1556, 1989 

  128. Cancer Res SA Maxwell 49 1130 1989 Maxwell SA, Sacks PJ, Gutterman GU, Gallick GE: Epidermal growth factor receptor protein-tyrosine kinase activity in human cell lines established from squamous carcinomas of the head and neck. Cancer Res 49: 1130?1137, 1989 

  129. Head Neck J Santini 13 132 1991 10.1002/hed.2880130209 Santini J, Formento JL, Francoval M, Milano G, Schneider M, Dassonville O, Dernard F: Characterization, quantitation and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head Neck 13: 132?139, 1991 

  130. Oncogene DTW Wong 2 67 1987 Wong DTW, Biswas DK: Expression of c-erb B oncogene in DMBA-induced hamster oral carcinomas. Oncogene 2: 67?72, 1987 

  131. Cancer Res JR Grandis 53 3579 1993 Grandis JR, Tweardy DJ: Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 53: 3579?3584, 1993 

  132. Cancer Res DM Shin 54 3153 1994 Shin DM, Ro JY, Hong WK, Hittelman WN: Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 54: 3153?3159, 1994 

  133. Int J Cancer JH Leonard 48 511 1991 10.1002/ijc.2910480406 Leonard JH, Kearsley JH, Chenevix-Trench G, Hayward NK: Analysis of gene amplification in the head and neck squamous cell carcinomas. Int J Cancer 48: 511?515, 1991 

  134. Cancer Res JB Faust 52 2460 1992 Faust JB, Meeker TC: Amplification and expression of the bcl-1 gene in human solid tumor cell lines. Cancer Res 52: 2460?2463, 1992 

  135. Proc Natl Acad Sci USA T Yoshida 84 7305 1987 10.1073/pnas.84.20.7305 Yoshida T, Miyagawa K, Odagiri H, Sakamoto H, Little PFR, Terada M: Genomic sequence of hst, a transforming gene encoding a protein homologous to fibroblast growth factors and the Int-2 encoded protein. Proc Natl Acad Sci USA 84: 7305?7309, 1987 

  136. Proc Natl Acad Sci USA CL Rosenberg 88 9638 1991 10.1073/pnas.88.21.9638 Rosenberg CL, Wong E, Petty EM, Balf AE, Tsujimoto Y, Harris NL, Arnold A: PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci USA 88: 9638?9642, 1991 

  137. Nature (Lond.) T Motokura 350 512 1991 10.1038/350512a0 Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, Arnold AA: A novel cyclin encoded by BCL-1-linked candidate oncogene. Nature (Lond.) 350: 512?515, 1991 

  138. Genes Chromosom Cancer J Kerlseder 9 43 1994 Kerlseder J, Zeillinger R, Schneeberger C, Czerwenka K, Speiser P, Kubista E, Birnbaum D, Gaudray P, Theillet C: Pattern of DNA amplification at band q13 of chromosome 11 in human breast cancer. Genes Chromosom Cancer 9: 43?48, 1994 

  139. Arch Otolaryngol Head Neck Surg ME Williams 119 1238 1993 10.1001/archotol.1993.01880230084013 Williams ME, Gaffey MJ, Weiss LM, Wilczynski SP, Schuuring E, Levine PA: Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 119: 1238?1243, 1993 

  140. Oncogene W Jiang 8 3447 1993 Jiang W, Kahn SM, Zhou P, Zhang Y, Cacace AM, Infante AS, Doi S, Santella RM, Weinstein IB: Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 8: 3447?3457, 1993 

  141. Cell SF Dowdy 73 499 1993 10.1016/0092-8674(93)90137-F Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberg RA: Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73: 499?511, 1993 

  142. Cell H Matsushine 71 323 1992 10.1016/0092-8674(92)90360-O Matsushine H, Ewin ME, Strom DK, Kato J-Y, Hanks SK, Roussel M, Sherr CJ: Identification and properties of an atypical catalytic subunit (p34 p5K-J3/cdk4) for mammalian D type G1 cyclins. Cell 71: 323?334, 1992 

  143. Oncogene S Bates 9 1633 1994 Bates S, Parry D, Bonetta L, Vousden K, Dickson C, Peters G: Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein. Oncogene 9: 1633?1640, 1994 

  144. Genes Dev DE Quelle 7 1559 1993 10.1101/gad.7.8.1559 Quelle DE, Ashmun RA, Shurtleff SA, Kato JY, Bar-Sagi D, Roussel MF, Sherr CJ: Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 7: 1559?1571, 1993 

  145. Proc Natl Acad Sci USA PH Hinds 91 709 1994 10.1073/pnas.91.2.709 Hinds PH, Dowdy SF, Eaton EN, Arnold A, Weinberg RA: Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 91: 709?713, 1994 

  146. Cancer T Callender 74 152 1994 10.1002/1097-0142(19940701)74:1<152::AID-CNCR2820740124>3.0.CO;2-K Callender T, El-Naggar AK, Lee MS, Frankenthaler R, Luna MA, Batsakis JG: PRAD-1(CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 74: 152?158, 1994 

  147. Int J Oncol O Parise 5 309 1994 Parise O, Janot F, Guerry R, Fortin A, Luboinski B, Tursz T, Schwaab G, Busson P: Cromosome 11q13 gene amplifications in head and neck squamous cell carcinomas: Relation with lymph node invasion. Int J Oncol 5: 309?313, 1994 

  148. Cancer Res R Michalides 55 975 1995 Michalides R, Van Veelen N, Hart A, Loftus B, Wientjens E, Balm A: Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 55: 975?978, 1995 

  149. Oncogene DE Lebwohl 9 1925 1994 Lebwohl DE, Muise-Helmericks R, Sepp-Lorenzino L, Serve S, Timaul M, Bol R, Borgen P, Rosen NA: A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line. Oncogene 9: 1925?1929, 1994 

  150. Proc Am Assoc Cancer Res HJ Roh 35 117 1994 Roh HJ, Shin DM, Lee JS, Ro JY, Tainsky MA, Hong WK, Hittelman WN: Visualization of int-2 amplification in premalignant lesions during head and neck tumorigenesis (Abstract). Proc Am Assoc Cancer Res 35: 117, 1994 

  151. Science LH Hartwell 266 1821 1994 10.1126/science.7997877 Hartwell LH, Kastan MB: Cell cycle control and cancer. Science 266: 1821?1828, 1994 

  152. Cancer Res MS Greenblatt 54 4855 1994 Greenblatt MS, Bennett WP, HOllstein M, Harris CC: Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855?4878, 1994 

  153. Cancer Res DG Brachman 52 4382 1992 Brachman DG, Graves D, Vokes E, Beckett M, Haraf D, Montag A, Dumphy E, Mick R, Yandell D, Weichselbaum RR: Occurrence of p53 gene deletion and human papilloma virus infection in head and neck cancer. Cancer Res 52: 4382?4386, 1992 

  154. Oncogene BA Gusterson 6 1785 1991 Gusterson BA, Anbazhagan R, Warren W, Midgely C, Lane DP, O'Hare M, Stamps A, Carter R, Jayatilake H: Expression of p53 in premalignant and malignant squamous epithelium. Oncogene 6: 1785?1789, 1991 

  155. Br J Cancer JK Field 64 573 1991 10.1038/bjc.1991.352 Field JK, Spandidos SA, Malliri A, Gosney JR, Yiagnisis M, Stell PM: Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinomas of the head and neck. Br J Cancer 64: 573?577, 1991 

  156. Cancer Res JO Boyle 53 4477 1993 Boyle JO, Koch W, Hruban RH, Van der Riet P, Sidransky D: The incidence of p53 mutations increase with progression of head and neck cancer. Cancer Res 53: 4477?4480, 1993 

  157. N Engl J Med JA Brennan 332 429 1995 10.1056/NEJM199502163320704 Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, Goodman SN, Sidransky D: Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 332: 429?435, 1995 

  158. Cancer Res DM Shin 54 321 1994 Shin DM, Kim J, Ro JY, Hittelman J, Roth JA, Hong WK, Hittelman WN: Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 54: 321?326, 1994 

  159. Nature (Lond.) A Ziegler 372 773 1994 10.1038/372773a0 Ziegler A, Jonason AS, Leffel DJ, Simon JA, Sharma HW, Kimmelman J, Remington L, Jacks T, Brash DE: Sunburn and p53 in the onset of skin cancer. Nature (Lond.) 372: 773?776, 1994 

  160. Proc Am Assoc Cancer Res DM Shin 35 944 1994 Shin DM, Ro JY, Shah T, Hong WK, Hittelman WN: p53 expression and genetic instability in head and neck multistep tumorigenesis (Abstract). Proc Am Assoc Cancer Res 35: 944, 1994 

  161. Cancer Res KY Chung 53 1676 1993 Chung KY, Mukhopadhyay T, Kim J, Casson A, Ro JY, Goepfert H, Hong WK, Roth JA: Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 53: 1676?1683, 1993 

  162. Cancer Res M Nees 53 4189 1993 Nees M, Homann N, Discher H, Andl T, Enders C, Harrold-Mende C, Schulmann A, Bosch FX: Expression of mutated p53 occurs in tumor-distant epithelial of head and neck cancer patients: A possible molecular basis for the development of multiple tumors. Cancer Res 53: 4189?4196, 1993 

  163. Cancer Res SM Lippman 55 16 1995 Lippman SM, Shin DM, Lee JJ, Batsakis JG, Lotan R, Tainsky MA, Hittelman WN, Hong WK: p53 and retinoid chemoprevention of oral carcinogenesis. Cancer Res 55: 16?19, 1995 

  164. N Engl J med SM Lippman 328 15 1993 10.1056/NEJM199301073280103 Lippman SM, Batsakis JG, Toth BB, Weber RS, Lee JJ, Martin JW, Hays GL, Goepfert H, Hong WK: Comparison of low-dose isotretinoin with beta-carotene to prevent oral carcinogenesis. N Engl J med 328: 15?20, 1993 

  165. Exp Cell Res SA Maxwell 214 67 1994 10.1006/excr.1994.1234 Maxwell SA. Mukhopadhyay T: Transient stabilization of p53 in non-small cell lung cultures arrested for growth by retinoic acid. Exp Cell Res 214: 67?74, 1994 

  166. Proc Am Soc Clin Oncol DM Shin 13 293 1994 Shin DM, Lee JS, Choi G, Shaw T, Hyne K, Earley C, Shin HJC, Ro JY, Hong WK, Hittelman WN: Prognostic significance of p53 expression in head and neck squamous cell carcinoma (HNSCC) (Abstract). Proc Am Soc Clin Oncol 13: 293, 1994 

  167. Cancer Res GL Clayman 55 1 1995 Clayman GL, El-Naggar AK, Roth LA, Zhang WW, Goepfert H, Taylor DL, Liu TJ: In vivo therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res 55: 1?6, 1995 

  168. Int J Cancer L Xu 59 383 1994 10.1002/ijc.2910590316 Xu L, Davidson BJ, Murty VVVS, Li R-G Sacks P, Garin-Chesa P, Schantz SP, Chaganti RSK: p53 gnee mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines. Int J Cancer 59: 383?387, 1994 

  169. Cancer Res J Bartkova 55 949 1995 Bartkova J, Lukas J, Muller J, Strauss M, Gusterson B, Bartek J: Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res 55: 949?956, 1995 

  170. Cell WS El-Deiry 75 817 1993 10.1016/0092-8674(93)90500-P El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer E, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817?825, 1993 

  171. Cell JW Harper 75 805 1993 10.1016/0092-8674(93)90499-G Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805?816, 1993 

  172. Cancer Res P Michieli 54 3391 1994 Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D: Induction of WAF1/C1P1 by a p53-independent pathway. Cancer Res 54: 3391?3395, 1994 

  173. Science (Washington, DC) SB Parker 267 1024 1995 10.1126/science.7863329 Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, Olson EN, Harper JW, Elledge SJ: p53-independent expression of p21Cipl in muscle and other terminally differentiating cells. Science (Washington, DC) 267: 1024?1027, 1995 

  174. Science (Washington, DC) O Halevy 267 1018 1995 10.1126/science.7863327 Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB: Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science (Washington, DC). 267: 1018?1021, 1995 

  175. Proc Am Assoc Cancer Res SJ Lee 36 581 1995 Lee SJ, Ha MJ, Lee J, Trepel JB: p53-independent induction of the cyclin-dependent kinase inhibitor p21 in prostate and breast carcinoma cells treated with an inhibitor of the HMG-CoA reductase pathway (Abstract). Proc Am Assoc Cancer Res 36: 581, 1995 

  176. Proc Am Assoc Cancer Res MS Hwang 36 10 1995 Hwang MS, Thompson KL, Ahn CH: p53-independent induction of p21WAF1 and apoptosis by all-trans-retinoic acid and 9-cis retinoic acid in human prostate cancer cell lines (Abstract). Proc Am Assoc Cancer Res 36: 10, 1995 

  177. Nature (Lond.) R Li 371 534 1994 10.1038/371534a0 Li R, Waga S, Hannon GJ, Beach D, Stillman B: Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature (Lond.) 371: 534?537, 1994 

  178. Blood M Shiohara 84 3781 1994 10.1182/blood.V84.11.3781.bloodjournal84113781 Shiohara M, El-Deiry WS, Wada M, Nakamaki T, Takeuchi S, Yang R, Chen DL, Vogelstein B, Koeffler HP: Absence of WAF1 mutations in a variety of human malignancies. Blood 84: 3781?3784, 1994 

  179. Cancer Res WS El-Deiry 55 2910 1995 El-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculescu VE, Burrell M, Hill DE, Healy E, Rees JL, Hamilton SR, Kinzler KW, Vogelstein B: Topological control of p21waf1/cip1 expression in normal and neoplastic tissues. Cancer Res 55: 2910?2919, 1995 

  180. J Clin Invest M Lipkin 42 767 1963 10.1172/JCI104769 Lipkin M, Bell B, Sherlock P: Cell proliferation kinetics in the gastrointestinal tract of man: I. Cell renewal in colon and rectum. J Clin Invest 42: 767, 1963 

  181. Gastroenterology M Lipkin 45 721 1963 10.1016/S0016-5085(19)34805-X Lipkin M, Sherlock P, Bell B: Cell proliferation kinetics in the gastrointestinal tract of man: II. Cell renewal in stomach, ileum, colon and rectum. Gastroenterology 45: 721, 1963 

  182. nature (Lond.) M Serrano 366 704 1993 10.1038/366704a0 Serrano M, Hannon G, Beach D: A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. nature (Lond.) 366: 704?707, 1993 

  183. Cancer Res P Riet Van der 54 1156 1994 Van der Riet P, Nawroz H, Hruban RH, Corio R, Tokino K, Koch W, Sidransky D: Frequent loss of chromosome 9p21?22 early in head and neck cancer progression. Cancer Res 54: 1156?1158, 1994 

  184. Science A Kamb 264 436 1994 10.1126/science.8153634 Kamb A, Gruis NA, Weaverfeldhaus J, Liu QY, Harshman K: A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436?440, 1994 

  185. Science (Washington, DC) P Cairns 265 415 1994 10.1126/science.8023167 Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, Van der Riet P, Blaugrund JE, Sidransky D: Low rate of p16 (MTS1) mutations in primary tumors with 9p loss. Science (Washington, DC) 265: 415?417, 1994 

  186. Cancer Res SY Zhang 54 5050 1994 Zhang SY, Klein-Szanto AJP, Sauter ER, Shafarenko M, Mitsunaga S, Nobori T, Carson DA, Ridge JA, Goodrow TL: Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res 54: 5050?5053, 1994 

  187. Genes Chromosom Cancer WM Lydiatt 13 94 1995 10.1002/gcc.2870130204 Lydiatt WM, Murty VVVS, Davidson BJ, Xu L, Dyomina K, Sacks PG, Schantz SP, Chaganti RSK: Homozygous deletions and loss of expression of the CDKN2 gene occur frequently in head and neck squamous cell carcinoma cell lines but infrequently in primary tumors. Genes Chromosom Cancer 13: 94?98, 1995 

  188. Science (Washington, DC) CH Spruck 265 415 1994 10.1126/science.8023167 Spruck CH, Gonzales-Zulueta M, Shibata A, Simoneau AR, Lin MF, Gonzales F, Tsai YC, Jones PA: p16 gene in uncultured tumors. Science (Washington, DC) 265: 415?416, 1994 

  189. Nature Med A Merlo 1 686 1995 10.1038/nm0795-686 Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger P, Baylin SB, Sidransky D: 5? CpG island methylation is associated with transciptional silencing of the tumor suppressor p16/CDKN2/MTSl in human cancers. Nature Med 1: 686?692, 1995 

  190. Nature (Lond.) R Bravo 326 515 1987 10.1038/326515a0 Bravo R, Frank R, Blundell PA, MacDonald-Bravo H: Cyclin/PCNA is the auxiliary protein of DNA polymerasedelta. Nature (Lond.) 326: 515?517, 1987 

  191. J Cell Sci R Baserga 98 433 1991 10.1242/jcs.98.4.433 Baserga R: Growth regulation of the PCNA gene. J Cell Sci 98: 433?436, 1991 

  192. Proc Natl Acad Sci USA JE Celis 82 326203266 1985 10.1073/pnas.82.10.3262 Celis JE, Celis A: Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: Subdivision of phase. Proc Natl Acad Sci USA 82: 326203266, 1985 

  193. J Natl Cancer Inst DM Shin 85 971 1993 10.1093/jnci/85.12.971 Shin DM, Voravud N, Ro JY, Lee JS, Hong WK, Hittelman WN: Sequential upregulation of proliferating cell nuclear antigen in head and neck tumorigenesis: A potential biomarker. J Natl Cancer Inst 85: 971?978, 1993 

  194. Oral Surg Oral Med Oral Pathol WY Huang 78 748 1994 10.1016/0030-4220(94)90091-4 Huang WY, Coltrera M, Schubert M, Morton T, Truelove E: Histopathologic evaluation of proliferating cell nuclear antigen (PC10) in oral epithelial hyperplasias and premalignant lesions. Oral Surg Oral Med Oral Pathol 78: 748?754, 1994 

  195. Virchows Arch V Gorgoulis 426 339 1995 10.1007/BF00191341 Gorgoulis V, Zoumpourlis V, Rassidakis G, Karameris A, Barbatis C, Spandidos DA, Kittas C: Molecular analysis of p53 gene in laryngeal premalignant and malignant lesions: p53 protein immunohistochemical expression is positively related to proliferating cell nuclear antigen labelling index. Virchows Arch 426: 339?344, 1995 

  196. Eur J Cancer B Oral Oncol SC Girod 30 419 1994 10.1016/0964-1955(94)90023-X Girod SC, Pape HD, Krueger GR: p53 and PCNA expression in carcinogenesis of the oropharyngeal mucosa. Eur J Cancer B Oral Oncol 30b: 419?423, 1994 

  197. Dermatologica AM Jetten 175 37 1987 10.1159/000248852 Jetten AM: Multistep process of squamous differentiation of tracheobronchial epithelial cells. Role of retinoids. Dermatologica 175: 37?44, 1987 

  198. Cell R Moll 31 11 1982 10.1016/0092-8674(82)90400-7 Moll R, Franke WW, Schiller DL: The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 31: 11?24, 1982 

  199. Proc Natl Acad Sci USA KH Kim 81 4280 1984 10.1073/pnas.81.14.4280 Kim KH, Schwartz F, Fuchs E: Difference sin keratin synthesis between normal epithelial cells and squamous cell carcinomas are mediated by vitamin A. Proc Natl Acad Sci USA 81: 4280?4284, 1984 

  200. Virchows Arch [B] AAJJL Rutten 56 111 1989 10.1007/BF02890009 Rutten AAJJL, Bruyntjes JP, Ramaekers FCS: Effect of cigarette smoke condensate and vitamin A depletion on keratin expression patterns in cultured hamster tracheal epithelium: An immunohistomorphological study using monoclonal antibodies to keratins. Virchows Arch [B] 56: 111?117, 1989 

  201. Am J Pathol K Lindberg 134 419 1989 Lindberg K, Rheinwald JG: Suprabasal 40 kd keratin (K19): Expression as immunohistological marker of premalignancy in oral epithelium. Am J Pathol 134: 419?426, 1989 

  202. Cancer Res IB Gimenez-Conti 50 4441 1990 Gimenez-Conti IB, Shin D, Bianchi AB, Roop DR, Hong WK, Conti CJ, Slaga TJ: Changes in keratin expression during 7,12-dimethylbenz(a) anthracene-induced hamster cheek pouch carcinogenesis. Cancer Res 50: 4441?4445, 1990 

  203. Cancer MP Copper 71 825 1993 10.1002/1097-0142(19930201)71:3<825::AID-CNCR2820710327>3.0.CO;2-X Copper MP, Braakhuis BJM, De Vries N, Van Dongen GAMS, Nauta JJ, Snow G: A panel of biomarkers of carcinogenesis of the upper aerodigestive tract as potential intermediate endpoints in chemoprevention trials. Cancer 71: 825?830, 1993 

  204. J Invest Dermatol SM Thatcher 92 578 1989 Thatcher SM: Purification of keratinocyte transglutaminase and its expression during squamous differentiation. J Invest Dermatol 92: 578?584, 1989 

  205. Lab Invest JW Said 49 563 1983 Said JW, Nash G, Sassoon AF, Shintaku IP, Banks-Schlegel S: Invoducrin in lung tumors: A specific marker for squamous differentiation. Lab Invest 49: 563?568, 1983 

  206. J Oral Pathol ME Itoiz 15 205 1986 10.1111/j.1600-0714.1986.tb00608.x Itoiz ME, Conti CJ, Gimenez-Conti JB, Lafranchi HE, Fernandez-Alonso GI, Klein-Szanto AJP: Immunodetection of involucrin in lesions of the oral mucosa. J Oral Pathol 15: 205?208, 1986 

  207. Head Neck Surg SM Lippman 12 5 1990 10.1002/hed.2880120103 Lippman SM, Lee JS, Lotan R, Hong WK: Chemoprevention of upper aerodigestive tract cancers: A report of the Upper Aerodigestive Cancer Task Force workshop. Head Neck Surg 12: 5?20, 1990 

  208. Biochim Biophys Acta R Lotan 605 33 1980 Lotan R: Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim Biophys Acta 605: 33?91, 1980 

  209. Proc Am Soc Clin Oncol S Lippman 8 168 1989 Lippman S, Toth B, Batsakis J: The evaluation of biologic markers as intermediate endpoints in a chemoprevention trial of 13-cis-retinoic acid (13cRA) in human premalignant oral lesions (Abstract). Proc Am Soc Clin Oncol 8: 168, 1989 

  210. Cancer Res TA Sellers 52 2694 1992 Sellers TA, Potter JD, Bailey-Wilson JE, Rich SS, Rothschild H, Elsta RC: Lung cancer detection and prevention: Evidence for an interaction between smoking and genetic predisposition. Cancer Res 52: 2694?2697, 1992 

  211. Carcinogenesis CC Harris 10 1563 1989 10.1093/carcin/10.9.1563 Harris CC: Interindividual variation among humans in carcinogen metabolism, DNA adduct formation and DNA repair. Carcinogenesis 10: 1563?1566, 1989 

  212. Cancer Res L Hagmar 54 2919 1994 Hagmar L, Brogger A, Hansteen IL, Heim S, Hogstedt B, Knudsen L, Lambert B, Linnainmaa K, Mitelman F, Nordenson I, Reuterwall C, Salomaa S, Skerfving S, Sorsa M: Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res 54: 2919?2922, 1994 

  213. In Vitro Cell Dev Biol TC Hsu 23 591 1987 10.1007/BF02621067 Hsu TC: Genetic predisposition to cancer with special reference to mutagen sensitivity. In Vitro Cell Dev Biol 23: 591?603, 1987 

  214. Cancer Res MR Spitz 49 4626 1989 Spitz MR, Fueger JJ, Beddingfield NA, Annegers JF, Hsu TC, Newell GR, Schantz SP: Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancer. Cancer Res 49: 4626?4628, 1989 

  215. Cancer Epidemiol Biomarkers Prev MR Spitz 2 329 1993 Spitz MR, Fueger JJ, Halabi S, Schantz SP, Sample D, Hsu TC: Mutagen sensitivity in upper aerodigestive tract cancer: A case control analysis. Cancer Epidemiol Biomarkers Prev 2: 329?333, 1993 

  216. J Natl Cancer Inst MR Spitz 86 1681 1994 10.1093/jnci/86.22.1681 Spitz MR, Hoque A, Trizna Z, Schantz SP, Amos CI, King TM, Bondy ML, Hong WK, Hsu TC: Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract. J Natl Cancer Inst 86: 1681?1684, 1994 

  217. Int J Cancer J Cloos 56 816 1994 10.1002/ijc.2910560610 Cloos J, Braakhuis BJ, Steen I, Copper MP, De Vries N, Nauta JJ, Snow GB: Increased mutagen sensitivity in head-and-neck squanmous-cell carcinoma patients, particularly those with multiple primary tumors. Int J Cancer 56: 816?819, 1994 

  218. Int J Oncol BJ Dave 5 733 1994 Dave BJ, Hsu TC, Hong WK, Pathak S: Nonrandom distribution of mutagen-induced chromosome breaks in lymphocytes of patients with different malignancies. Int J Oncol 5: 733?740, 1994 

  219. Cancer Bull KA McGlynn 46 220 1994 McGlynn KA, Buetow KH: Metabolic and H-ras polymorphisms in genetic susceptibility. Cancer Bull 46: 220?227, 1994 

  220. Cancer Treat Rep SM Lippman 71 391 1987 Lippman SM, Kessler JF, Meyskens FL: Retinoids as preventive and therapeutic anticancer agents. Cancer Treat Rep 71: 391?405, 1987 

  221. Moon TE, Cartmel B, Levine N, Arizona Skin Cancer Study Group: Chemoprevention and etiology of non-melanoma skin cancers, program, and abstracts. 17th Annual Meeting of the American Society of Preventive Oncology, Tucson, March 20?23, 1993 

  222. J Natl Cancer Inst FL Meyskens 86 539 1994 10.1093/jnci/86.7.539 Meyskens FL, Surwit E, Moon TE, Cilders JM, Davis JR, Dorr RT, Johnson CS, Alberts DS: Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: A randomized trial. J Natl Cancer Inst 86: 539?543, 1994 

  223. Am J Clin Oncol U Pastorino 11 1216 1993 10.1200/JCO.1993.11.7.1216 Pastorino U, Ifante M, Maioli M: Adjuvant treatment of stage I lung cancer with high-dose vitamin. Am J Clin Oncol 11: 1216?1222, 1993 

  224. N Engl J Med KH Kraemer 318 1633 1988 10.1056/NEJM198806233182501 Kraemer KH, DiGiovanna JJ, Moshell AN Tarone RE, Deck GL: Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med 318: 1633?1637, 1988 

  225. J Clin Oncol MA Smith 10 839 1992 10.1200/JCO.1992.10.5.839 Smith MA, Parkinson DR, Cheson BD, Friedman MA: Retinoids in cancer therapy. J Clin Oncol 10: 839?864, 1992 

  226. LJ Gudas 443 1994 The Retinoids: Biology, Chemistry, and Medicine Gudas LJ, Sporn MB, Roberts AB: Cellular biology and biochemistry of the retinoids. In: Sporn MB, Roberts AB, Goodman DS (eds) The Retinoids: Biology, Chemistry, and Medicine. Reven Press, New York, 1994, pp 443?520 

  227. R Lotan 43 1993 Retinoids in Oncology Lotan R: Retinoids and squamous cell differentiation. In: Hong WK, Lotan R (eds) Retinoids in Oncology. Marcel Dekker, New York, 1993, pp 43?72 

  228. Cancer Res EC Borden 53 4109 1993 Borden EC, Lotan R, Levens D, Young CW, Waxman S: Differentiation therapy of cancer: laboratory and clinical investigations (meeting report). Cancer Res 53: 4109?4115, 1993 

  229. P Leroy 1992 Retinoids in Normal Development and Teratogenesis Leroy P, Krust A, Kastner P, Mendelsohn C, Zelent A, Chambon P: Retinoic acid receptors. In: Morriss-Kay G (ed) Retinoids in Normal Development and Teratogenesis. Oxford University Press, New York, 1992, pp 7025 

  230. Blood M Huang 72 567 1988 10.1182/blood.V72.2.567.567 Huang M, Ye Y, Chen S, Chai J, Lu J, Zhoa L, Gu L, Wang Z: Use of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72: 567?572, 1988 

  231. Oncogene MM Moasser 9 833 1994 Moasser MM, DeBlasio A, Dmitrovsky E: Response and resistance to retinoic acid are mediated through the retinoic acid nuclear receptor gamma in human teratocarcinomas. Oncogene 9: 833?840, 1994 

  232. Cancer Res CP Zou 54 5479 1994 Zou CP, Clifford JL, Xu XC, Sacks PG, Chambon P, Hong WK, Lotan R: Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines. Cancer Res 54: 5479?5487, 1994 

  233. Cancer Res XC Xu 54 3580 1994 Xu XC, Ro JY, Lee JS, Shin DM, Hong WK, Lotan R: Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res 54: 3580?3587, 1994 

  234. Proc Am Soc Clin Oncol R Lotan 14 61 1995 Lotan R, Sozzi G, Ro J, Lee J, Pastorino U, Pilotti S, Kurie J, Hong WK, Xu X: Selective suppression of retinoic acid receptor ? (RAR ?) expression in squamous metaplasia, and in non-small cell lung cancers (NSCLC) compared to normal bronchial epithelium (Abstract). Proc Am Soc Clin Oncol 14: 61, 1995 

  235. Cancer Res L Hu 51 3972 1991 Hu L, Crowe DL, Rheiwald JG, Chambon P, Gudas LJ: Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res 51: 3972?3981, 1991 

  236. Oncogene JF Gebert 6 1859 1991 Gebert JF, Moghal N, Frangioni JV, Sugarbaker DJ, Neel BG: High frequency of retinoic acid receptor beta abnormalities in human lung cancer. Oncogene 6: 1859?1868, 1991 

  237. N Engl J Med R Lotan 332 1405 1995 10.1056/NEJM199505253322103 Lotan R, Xu X-C, Lippman SM, Ro JY, Lee JS, Lee JJ, Hong WK: Suppression of retinoic acid receptor ? in premalignant oral lesions and its upregulation by isotretinoin. N Engl J Med 332: 1405?1410, 1995 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로